CGEN
Compugen Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.03
+1.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 29.78x
Trailing multiples
Trailing twelve months
- P/E TTM
- 5.41x
- PEG TTM
- —
- Price / book
- 2.17x
- Price / sales
- 2.60x
- Price / cash flow
- —
Enterprise value
- Enterprise value
- $70.0M
- EV / sales
- 0.95x
- EV / EBITDA
- 1.99x
- EV / EBIT
- 2.31x
- Market cap
- $192.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026